fashion -WSS

fashion

author：focus 2025-10-01 17:34:52 - browse：6

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Stop Congress from blocking public access to science

explore

WSS

Will an HIV vaccine ever be a reality?

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

New oral drug delivery patch is modeled after octopus tentacles

With Roe v Wade overturned, abortion providers work to adapt

Experts study whether long Covid risk adds up with each reinfection

Experts study whether long Covid risk adds up with each reinfection

focus

fashion

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Nobel honors Karikó and Weissman's enduring partnership

How one medical school became remarkably diverse

6 solutions to address cancer drug shortages and others

In Memoriam: Notable people who died in 2023

6 solutions to address cancer drug shortages and others

New air purifier tech could be key to improving indoor air quality

Health insurers' Q3 question: how much care are people getting?

Cancer drug shortages should be causing more outrage

The United States is paying nearly triple for new Covid vaccines

Wikipedia

Britney Spears to release memoir, 'The Woman In Me,' later this year

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Vermont grapples with historic flooding as more rainstorms head for Northeast

Watch the official trailer for 'Ahsoka' series

Grail's uphill battle for Medicare to cover its cancer screening test

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

explore

focus

entertainment

focus